Transcriptome wide changes in human skeletal muscle after acute (anabolic) and chronic resistance exercise (RE) induced hypertrophy have been extensively determined in the literature. We have also recently undertaken DNA methylome analysis (850,000 + CpG sites) in human skeletal muscle after acute and chronic RE, detaining and retraining, where we identified a role for DNA methylation in an epigenetic memory of exercise induced skeletal muscle hypertrophy. However, it is currently unknown as to whether all the genes identified in the transcriptome studies to date are also epigenetically regulated at the DNA level after acute, chronic or repeated RE exposure. We therefore aimed to undertake large scale bioinformatical analysis by pooling the publicly available transcriptome data after acute (110 samples) and chronic RE (181 samples) and comparing these large data sets with our genome-wide DNA methylation analysis in human skeletal muscle after acute and chronic RE, detraining and retraining. Indeed, after acute RE we identified 866 up-and 936 down-regulated genes at the expression level, with 270 (out of the 866 up-regulated) identified as being hypomethylated, and 216 (out of 936 downregulated) as hypermethylated. After chronic RE we identified 2,018 up-and 430 down-regulated genes with 592 (out of 2,018 upregulated) identified as being hypomethylated and 98 (out of 430 genes downregulated) as hypermethylated. After KEGG pathway analysis, genes associated with 'cancer' pathways were significantly enriched in both bioinformatic analysis of the pooled transcriptome and methylome data after both acute and chronic RE. This resulted in 23 (out of 69) and 28 (out of 49) upregulated and hypomethylated and 12 (out of 37) and 2 (out of 4) downregulated and hypermethylated 'cancer' genes following acute and chronic RE respectively. Within skeletal muscle tissue, these 'cancer' genes predominant functions were associated with matrix/ actin structure and remodelling, mechano-transduction (including PTK2/Focal Adhesion Kinase and Phospholipase Dfollowing chronic RE only), TGF-beta signalling and protein synthesis (GSK3B after acute RE only).
Introduction
Skeletal muscle tissue demonstrates extensive plasticity, responding dynamically to sustained mechanical loading and contraction with muscle hypertrophy. However, skeletal muscle tissue also wastes (atrophy) rapidly during periods of disuse, for example, following an injury from a fall or reduces in size overtime as a result of ageing (sarcopenia, reviewed in 1,2 ). The transcriptome wide changes in gene expression that regulate healthy adult human skeletal muscle anabolism and hypertrophy in response to acute and chronic resistance exercise (RE) respectively have been reported in the literature [3] [4] [5] [6] [7] [8] [9] [10] . Ultimately, the identification of genes associated with skeletal muscle mass regulation continue to progress this field of research in order to optimise the growth response to resistance exercise and help prevent muscle wasting. Despite these recent advances, it is currently unknown as to whether the genes identified at the mRNA level across the transcriptome are also epigenetically regulated at the DNA level.
Epigenetics is the study of DNA that is modified as a result of an encounter with the environment. These DNA modifications subsequently affect genes at the transcript level. The major forms of DNA modification include alterations to the surrounding histones as a result of methylation, acetylation and deacetylation.
Histone modifications lead to the DNA being rendered into a repressive (inhibitory) or permissive (allowing) state, that subsequently alters access for the transcriptional machinery regulating gene expression.
DNA itself can also be modified directly by methylation, via the addition or removal of methyl groups, particularly to cytosine-guanine base pairing (CpG) sites. For example, increased DNA methylation (hypermethylation) that occurs in the fifth position of a cytosine (5mC) residue of a CpG site, particularly if present in the promoter or enhancer region of a gene, can attenuate the performance of transcriptional apparatus and can cause a reduction in the expression of a specific gene 11 . On the other hand, a reduction in DNA methylation (hypomethylation) can improve the function of transcription factors and therefore enhance gene expression 11 .
We have recently characterised genome-wide DNA methylation of over 850,000 CpG sites across the human genome in skeletal muscle at rest (baseline), after acute resistance exercise (acute RE), chronic resistance exercise induced hypertrophy (training/loading), followed by a period of detaining (where muscle returned to baseline-termed unloading), and finally after retraining induced hypertrophy (retraining/reloading) 12 . Therefore, in the present study we aimed to identify if transcriptome wide gene expression changes were associated with DNA methylation of the same genes across the genome (methylome) after acute and chronic RE. In order to achieve this aim, we undertook large scale bioinformatical analysis that pooled the publicly available transcriptome data sets from human skeletal muscle pre/post-acute (110 gene array samples) and chronic (181 gene array samples) resistance exercise and overlapped this with the genome-wide DNA methylation after acute and chronic resistance exercise from our recent study 12 .
Finally, we have recently demonstrated that skeletal muscle has an epigenetic memory 12, 13 . Where, DNA methylation signatures (particularly hypomethylation) were retained even when exercise ceased during detraining (and lean mass was returned to pre-exercise levels) following chronic RE induced hypertrophy in humans, leading to an advantageous state for these genes to be further upregulated when later retaining induced hypertrophy was encountered 12 . However, in this study we did not perform transcriptome wide gene expression analyses, opting instead for targeted gene expression analysis of those genes that mapped to the most significantly regulated CpG sites. Therefore, the secondary aim of the present study was to identify if transcriptome wide gene expression changes from pooled publicly available data sets after acute and chronic RE, were associated with the methylome changes seen during training, detraining and retaining in our epigenetic muscle memory studies.
Overall, we hypothesised that we would identify new epigenetically regulated genes and gene pathways in human skeletal muscle anabolism, hypertrophy and those associated with epigenetic muscle memory. We also hypothesised that transcriptome wide changes identified in the pooled transcriptome analysis after acute and chronic RE would be associated with altered DNA methylation of some of the same genes after training, detraining and retraining.
Methods

Identification of transcriptomic studies
The studies used for pooled transcriptome analysis for both acute and chronic resistance exercise (RE) are summarised in Suppl. File 1. These include publicly available transcriptome data sets deposited and searchable before the end of April 2018. In order to enable a suitable comparison of the transcriptomic studies after acute and chronic RE in humans we incorporated the following inclusion and exclusion criteria in our search. For acute RE, we included all transcriptome array data from the skeletal muscle of young healthy adult males in order to enable the comparison with the genome-wide DNA methylation analysis that was undertaken in the same population in 12 . Resistance exercise intensity was not an exclusion criterion per se, however no aerobic, continuous or concurrent exercise studies were included. All time points of isolated RNA from biopsies that were within the first 24 hrs post an acute bout of RE were included, and samples taken after 24 hrs were excluded. Due to the varied time points at which RNA was sampled following acute RE, with only a small number of studies sampling at the same timepoint, all samples taken immediately post exercise and up to 24 hrs were attributed to the same post-acute RE biopsy condition for the pooled transcriptome analysis. Furthermore, within studies, if there were multiple time points of biopsy sampling, all times points were included up to 24 hrs and attributed within the same post-acute RE biopsy condition for the analysis. We excluded any study with less than 10,000 gene probe-sets annotated by 'gene symbol'.
These studies used earlier gene array platforms with a low number of gene transcripts analysed versus more recent data sets with approximately 20,000 or more gene transcripts. When including the studies with 10,000 probe-sets or less, this dramatically affected the number of the same genes that were assessed between studies and meant that we could not accurately compare any of the larger more recent studies that used the latest gene array platforms. For chronic RE transcriptome data, we included young heathy adult males both pre and post chronic RE with biopsies taken at rest. There was no set frequency, duration or intensity of REalthough minimum frequency and duration for the chronic RE studies was 12 weeks resistance exercise 2 times per week (detailed in Suppl. File 1). As in the acute analysis above, we excluded probe sets below 10,000 annotated genes by 'gene symbol.' A table of all studies can be found in Suppl. File 1.
Bioinformatic Pooled Transcriptome Analysis
All available data sets were downloaded from NIH data base, Gene Expression Omnibus (GEO), website and imported into Partek Genomics Suite software (version 7.18.0518, Partek Inc. Missouri, USA) as .CEL or .TXT files for both acute and chronic RE studies independently. The relevant gene array platform annotation file, also downloaded from GEO, was then assigned to the appropriate data set. For the majority of the data sets, it was stated on GEO, that samples were normalised via the Robust Multi-array Average (RMA) method (that includes Log2 transformation) upon import. If data were normalised but not Log2 transformed (for example if data was MAS5 normalised upon import), these were subsequently Log2 transformed. For genes that were detected by more than one probe set we selected the highest-scoring probe set to represent that gene in order to allow a comparison of the unambiguous expression estimate of an individual gene, and compare it across studies/array platforms. This has previously been defined as a relevant method to account for altered hybridisation efficiency across multiple probe sets for the same gene and across array platforms 14, 15 . To be able to directly compare gene expression between studies, we then identified a list of the common gene symbol annotations across all studies. This allowed us to filter each individual data set by gene symbols that were uniformly shared across the different array platforms, subsequently allowing comparison of identical genes across all included studies. All filtered acute RE or chronic RE data sets were then merged together and samples that did not satisfy the inclusion/exclusion criteria described above, were removed. Sample attributes were then defined as 'pre' or 'post' acute RE and 'pre' or 'post' chronic RE, also in line with the inclusion/exclusion criteria stated above. Quality assurance (QA) and control (QC) analyses were undertaken on both the acute and chronic study data sets independently. Principal component analysis, box/whisker charts and sample frequency/density plots by lines were produced for both the merged acute RE and chronic RE data sets. Samples were then excluded via PCA analysis if they deviated 2 standard deviations from the mean values of the group (using ellipsoidssee figures/legends for details) for the time attribute (pre or post) or within each study. To correct for differences in processing methods of the samples across studies, we performed batch correction using Partek Genomics Suite 'Remove Batch Effects' tool, previously reported as an appropriate batch correction tool when dealing with data of non-trivial size (i.e. several samples per condition 16, 17 ). Specific and detailed description of QA/QC and batch removal can be seen in the appropriate figure legends. Detection of differentially expressed genes was then performed on Partek using an ANOVA for both acute and chronic RE (Pre vs. Post contrast) (version 7.18.0518) and a gene list of all the significantly (P ≤ 0.01) differentially regulated genes (both up and down) was created.
Overlapping of Pooled Transcriptome Analysis with the DNA Methylome
Using Venn diagram analysis, the significant differentially regulated gene lists generated from the pooled transcriptomic gene expression analysis described above were overlapped with the significantly differentially modified CpG sites lists from the freely available supplementary files of 12 , after both acute RE and chronic RE (latter termed 'loading' in the original article), detraining (unloading) and retaining (reloading). Genome-wide DNA methylation data were therefore processed as previously defined in the original data 12 and a recently published data descriptor for the original study 18 . Briefly, raw .IDAT files were processed on Partek Genomic Suite V.6.6 (Partek Inc. Missouri, USA) and background normalisation was performed via the Subset-Quantile Within Array Normalisation (SWAN) method 19 and imported using the MethylationEPIC_v-1-0_B2.bpm manifest file. This analysis enabled us to compare genes that were both up/downregulated at the expression level and hypo/hypermethylated at the DNA level after both acute and chronic RE. It also allowed us to associate genes that were up/down regulated in the comparative transcriptome analysis after acute and chronic RE that were hypo/hypermethylated at the DNA level after acute RE, training, detaining and retaining.
Pathway Analysis
Using statistically generated gene expression and CpG data (detailed above), KEGG signalling pathway analysis [20] [21] [22] (see results/figures for significance level of enrichment P values) was performed in Partek Genomic Suite and Partek Pathway.
Target Gene Expression of FLNB by rt-qRT-PCR
Human skeletal muscle RNA previously derived in 12 was reanalysed and used in the present study. The RNA was originally isolated from biopsies taken from the vastus lateralis of young adult males. Participant characteristics, full biopsy and RNA isolation procedures are described in 12, 18 . RNA from baseline, 30 
Results
Pooled Transcriptome Analysis overlapped with the Methylome in Human Skeletal Muscle after Acute
Resistance Exercise
In total, 110 gene arrays from skeletal muscle biopsies were used for pooled transcriptome analysis, File 2B). This equated to 355 different CpG sites on these 270 genes as some individual genes had more than one CpG site that was hypomethylated per gene (Suppl. File 2C). Furthermore, out of 936 downregulated genes there were 216 genes across pooled transcriptome studies that were also hypermethylated in the methylome analysis, Figure 1K , Suppl. File 2D). This equated to 268 CpG sites on these 216 genes (Suppl. File 2E).
Cancer Pathways are Enriched in both the Transcriptome and Methylome Data Sets in Human Skeletal
Muscle after Acute Resistance Exercise Other than these two cancer pathways, none of the other top 20 enriched pathways in the pooled transcriptome gene expression analysis were the same as those identified in the top 20 enriched DNA methylation pathways in the methylome analysis (Suppl. File 3A and 3B, respectively).
Out of the genes up (69) and down regulated (37) across these 'cancer' pathways (Suppl. File 3G & 3H respectively), we then overlapped the genes that were hypo/hypermethylated respectively after acute RE in 12 ( Figure 4A & B ). This analysis identified 23 'cancer' transcripts ( Figure 4A ; Suppl. File 3I) that were upregulated in the pooled transcriptome analysis that also demonstrated significant hypomethylation on the same gene following acute RE, this related to 29 CpG sites mapping to the 23 transcripts (as some genes had more than 1 CpG site modification per gene). This included genes: MSN, FOS, THBS1, ITPR3, TIMP3,   RARA, FLNB, LAMA5, RASSF5, CRK, SMAD3, STAT3, COL4A1, ITGA2, WNT9A, ITGB3, KDR,   ADCY3 , CTTN, CD63, DOT1L, F2RL3 and GSK3B ( Figure 4A ; Suppl. File 3J). The largest proportion (57%) of the CpG's were located in a promotor region for the same gene (for at least one their gene transcripts; Suppl. File 3J). In skeletal muscle most of these genes (13 out of 23) are associated with matrix / actin structure or remodelling and mechano-transduction (MSN, THBS1, TIMP3, FLNB, LAMA5, CRK, COL4A1, ITGA2, ITGB3, CD63, CTTN, RASSF5, F2RL3). With 3 genes associated with TGF-Beta signalling (SMAD3, FOS, WNT9A), 2 genes with calcium signalling (ITPR3, ADCY3), and 1 gene with IL-6 signalling (STAT3), protein synthesis (GSK3B) and retinoic acid signalling (RARA). Finally, after acute RE we identified 12 different 'cancer' genes ( Figure 4B ; Suppl. File 3K) that were downregulated in the comparative gene expression analysis that were also hypermethylated on 14 CpG sites in the methylome analysis 12 , (as some genes had more than 1 CpG site modification). This included genes RUNX1T1, GAB1, ESR1, LAMA3, NANOG, SMO, ANK3, GADD45G, DROSHA, ATM, APAF1 and AGTR1 ( Figure 4B ;
Suppl. File 3K), with varied functions in skeletal muscle (see discussion). Again, the largest proportion (64%) of the CpG's were also located in a promotor region for the same gene (for at least one of their gene transcripts; Suppl. File 3L).
Pooled Transcriptome Analysis overlapped with the Methylome in Human skeletal Muscle after Chronic
Resistance Exercise 'Pathways in cancer' and 'Proteoglycans in Cancer' pathways after chronic RE were also identified in the above analysis to be significantly enriched after acute RE at both the transcriptome and methylome level.
Furthermore, these were the only 2 out of 3 pathways that were in the top 20 enriched pathways identified in both acute and chronic RE pooled transcriptome analyses (the only other being the 'Amoebiasis' pathway).
Therefore, as with the acute RE analysis above, we sought to analyse these cancer pathways in more detail after chronic RE. Indeed, these 2 cancer pathways combined included a total of 123 cancer related genes, 108 of which were unique genes (as some were shared/included in both cancer pathways). Out of these 108 genes that were up/down regulated we identified that 53 of these cancer genes were also modified at the DNA methylation level ( Figure 10A ). Of these 53 genes, this related to 91 different CpG's (as some genes had more than 1 CpG site modification). From these 53 genes, 49 were upregulated (Suppl. File 6A) and we identified that 28 of these upregulated genes ( Figure 10A ; Suppl. File 6B) contained 40 hypomethylated
CpG sites that mapped to these 28 transcripts, as some genes had more than modified CpG site ( Figure 10A ;
Suppl. File 6C). This included genes: COL4A2, HSPG2, MECOM, TGFB3, ITGA6, TCF7L1, TIAM1, CTTN, CASP8, GNA12, ADCY4, BCR, PTK2, PLCG2, CCNA1, FN1, LEF1, PLCB4, ITPR1, PLD1, TGFBR2, PDCD4, FLNB, PLAUR, HOXD10, HSPB2, CXCL8 and EZR (gene expression and methylation fold change of these genes can be seen in Figure 10A ; 
Epigenetically regulated muscle 'memory' genes highlighted in the analysis
It has been recently identified that following chronic RE training induced hypertrophy a number of CpG sites remained hypomethylated during detraining, even when exercise ceased and muscle returned to baseline/pre-exercise levels, with this hypomethylation also continuing through to a later period of retraining induced muscle hypertrophy 12 . We therefore sought to identify if the same genes that were significantly regulated in the pooled transcriptome analysis after acute and chronic RE were also identified to be modified in the methylome after acute RE, training, detraining and retraining. Indeed, we identified 51 genes that pre/baseline) and retraining (reloading) (1.38 fold ± 0.5 SEM vs. pre/baseline) ( Figure 12 ). However, these increases failed to reach statistical significance. Yet, this did demonstrate and inverse relationship with DNA methylation (hypomethylation after acute RE that was sustained throughout training, detraining and retraining, Figure 12 ).
Discussion
In the present study we undertook bioinformatic analysis and identified significantly up and down regulated genes across publicly available transcriptome studies after acute and chronic resistance exercise in human skeletal muscle. We then overlapped this with recent data that measured the DNA methylome response after acute resistance exercise (acute RE), chronic RE (loading/training), detraining (unloading) and retaining (reloading) 12 . We had the specific aim to identify novel genes/gene expression pathways that were epigenetically regulated at the DNA methylation level after acute anabolic exercise, chronic resistance exercise induced hypertrophy and those associated with an epigenetic memory. upregulated and 12 downregulated 'cancer' genes that were also hypo/ hypermethylated, respectively. The largest proportion of the CpG sites (57%) on these 'cancer' associated genes were promoter associated.
KEGG Cancer
Modification of site specific methylation in the promotor region of coding gene sequences is known to be an important regulator of the down-stream expression of the transcript, largely due to manipulation of binding and accessibility of polymerase apparatus 11 . We therefore identified an important role for DNA methylation in the promoter regions of genes within human skeletal muscle after acute RE, adding to previous work with similar findings in endurance exercise 24 . Of these 35 'cancer' genes, 23 were upregulated and hypomethylated, with a large proportion of these genes (13 out of 23) known to be important in matrix / actin structure and remodelling as well as mechano-transduction in skeletal muscle including: MSN, THBS1, TIMP3, FLNB, LAMA5, CRK, COL4A1, ITGA2, ITGB3, CD63, CTTN, RASSF5, F2RL3 (full gene names and general function is included in Suppl. File 8). Importantly, some of these ECM/actin structural and remodelling genes have been shown to demonstrate increases after aerobic or resistance exercise at the gene expression, protein abundance or activity level such as; TIMP3 25 , FLNB 26 , COL4A1 27, 28 , or are involved in satellite/muscle cell regulation (ITGB3 29 , CTTN 30 , LAMA5 31 , CRK 32, 33 ). However, to the authors knowledge there is no evidence to suggest that any of these genes are differentially methylated at the DNA level in skeletal muscle anabolism or hypertrophy. Therefore, the present study demonstrates for the first time, that important skeletal muscle genes/ gene pathways are also epigenetically regulated via DNA methylation, and that this predominantly occurs via the hypomethylation and upregulation of genes associated with structure and remodelling of the matrix and cytoskeleton as well as mechano-transduction in skeletal muscle.
It is also worth noting that a further 10 genes after acute RE were significantly differentially regulated and enriched in 'cancer' pathways within both the transcriptome (upregulated) and methylome (hypomethylated) analysis, and included 3 genes associated with TGF-beta signalling (FOS, SMAD3, WNT9A), 2 genes with calcium signalling (ITPR, ADCY) and 1 gene with IL-6 signalling (STAT3), protein synthesis (GSK3B) and retinoic acid signalling (RARA). TGF-Beta signalling is a major growth regulator, and has been demonstrated to be important in skeletal muscle mass regulation and exercise adaptation. Indeed, we demonstrate increased expression and hypomethylation of FOS (or c-FOS) downstream of TGF-Beta, previously highlighted to be upregulated at the gene expression level after 30 minutes running 34 and after resistance exercise in rats 35 , as well as post 2 hrs RE in humans 36 . We also demonstrated increased expression/hypomethylation of SMAD3 (intracellular signal transducer and transcriptional modulator), known to be activated by TGF-beta and activin type 1 receptor kinases 37 . However, in opposition with the current data, SMAD3 is increased in atrophy where muscle-specific knock-down of Smad2/3 in rodents protects from muscle atrophy following denervation 38 . Yet, in support of the present study, it has recently been demonstrated that SMAD/JNK axis is important for muscle size regulation after resistance exercise, but not after aerobic exercise 39 . Also, associated with TGF-Beta, the gene WNT9A was hypomethylated and upregulated, where it functions in the canonical Wnt/beta-catenin signalling pathway and has been identified, together with TGF-Beta2 and FGFR4, to be a key gene for the differentiation of muscle satellite cells 40 . The calcium signalling genes that were upregulated and hypomethylated included; ITPR3 (or IP3R
3 -Inositol 1,4,5-trisphosphate receptor type/isoform 3) that has been associated with Ca2+ signals leading to gene regulation in skeletal muscle cells that contribute to muscle fibre growth and NMJ stabilization 41 .
While ADCY3 has no clearly defined role in skeletal muscle, it catalyzes the formation of the signalling molecule cAMP in response to G-protein signalling 42 , and regulates Ca 2+ -dependent insulin secretion. Its methylation has been demonstrated to change in adipose tissue in response to altered nutrition 43 , but no methylation data currently exists in skeletal muscle.
We also demonstrate increases in gene expression and hypomethylation of other important genes in muscle;
STAT 3, GSK3B and RARA. Indeed, STAT3 is downstream of IL-6, and is known to play a critical role in regulating skeletal muscle mass, repair and is associated with myopathy (recently reviewed here 44 ).
However, while it has been shown to have increased protein activity after resistance exercise 45 , recent studies have shown that it is not required for overload induced hypertrophy in rodents 46 . The important protein synthesis regulator, GSK3B (Glycogen synthase kinase-3 beta), regulates protein synthesis by controlling the activity of initiation factor 2B (EIF2BE/EIF2B5), and has previously been shown to increase after resistance exercise and decrease during skeletal muscle atrophy 47 . Finally, RARA (Retinoic acid receptor alpha), important in skeletal muscle repair and satellite cell self-renewal 47 48 , is also upregulated and hypomethylated. Once again, to the authors knowledge there is no previous evidence to suggest that any of these transcripts are differentially methylated in skeletal muscle anabolism or hypertrophy. Further demonstrating the potential role DNA methylation plays in modulating the anabolic response of skeletal muscle mass after acute RE.
Of the above 35 'cancer' genes up/downregulated after acute RE, we also demonstrated that 12 were downregulated and hypermethylated, including: RUNX1T1, GAB1, ESR1, LAMA3, NANOG, SMO, ANK3, GADD45G, DROSHA, ATM, APAF1 and AGTR1. These genes related to several different functions within skeletal muscle and with the exception of those relating to apoptosis (GADD45G, ATM, APAF1), display very limited connection to one-another. Most notably for skeletal muscle, however, ESR1
(estrogen receptor 1) in the present study was hypermethylated with reduced gene expression in the young adult males after acute RE, whereas in female mice after knock-down, it has been shown to cause muscle weakness 49 yet, overexpression can result in a slow muscle fibre phenotype 50 . Therefore, a reduction observed in the adult males may therefore be associated with reduced slow fibre formation and subsequently may be conducive to faster fibre formation, previously identified to occur after resistance exercise. The association of hypermethylated and downregulation of ESR1 and its role in fibre type transition requires further investigation. notably COL4A2, HSPG2, TIAM1, CTTN, PTK2/FAK, PLD1 and PLAUR. Indeed, the responsiveness of COL4A2 (Type IV collagen) to muscle unloading and reloading seems to be impaired in aged muscle of rats 28 . Further, HSPG2 (Perlecan) has been identified to alter mass and metabolism in skeletal muscle 51 .
TIAM1 has been associated with skeletal muscle glucose uptake 52 . CTTN (cortactin) contributes to the organization of the actin cytoskeleton 53 and is also important in actin filament remodelling in L6 myotubes 30 . The abundance of FN1 (fibronectin) is blunted in elderly human skeletal muscle following muscle damage evoked via eccentric muscle contraction, compared to young healthy controls 54 . PLAUR acts as a receptor for urokinase plasminogen (uPA) with uPA-null mice demonstrating a complete lack of hypertrophy in response to synergistic ablation 55 . Also, while there are limited studies for the role of FLNB (filamin B) in skeletal muscle or resistance exercise induced hypertrophy, its loss has recently been highlighted to be associated with several myopathies and therefore a potential interesting target in skeletal muscle adaptation 26 . Further, its closely related genes/protein family members, such as filamin A (FLNA) have been identified as a substrate of Akt and phosphorylated after endurance exercise, but not resistance exercise 56 , and filamin C (FLNC) has been demonstrated to be closely associated with autophagy processes after resistance exercise 57 . These findings therefore suggest FLNB requires further attention as to its role in skeletal muscle anabolism and hypertrophy.
Most interestingly in this group of identified hypomethylated and upregulated genes, PTK2 (Focal adhesion kinase/FAK) has been previously identified as an important regulator of mechanical loading in skeletal muscle, as it is predominantly located within the costamere (a mechano-sensory site of focal adhesion in the sarcolemma). FAK increases at the protein activity level after resistance exercise in human skeletal muscle, with its increased activation elevated to the largest extent after eccentric contraction 58 . Furthermore, overexpression of FAK can have a protective effect on skeletal muscle reperfusion injury after limb ischemia 59 , and increasing FAK can also increase the β 1-integrin and meta-vinculin (+88%) content in skeletal muscle 60 . PLD-1 is another major mechano-sensor that has been explicitly linked with numerous functions in skeletal muscle, where it has been shown to be fundamental for muscle cell differentiation 61 , as well as myotube size via the activation of mechanistic target of rapamycin (mTOR) 62 . Importantly in rodents, the activation of mTOR following eccentric lengthening contractions occurs through a PI3K-PKBindependent mechanism, a process that requires upstream PLD and phosphatidic acid 63 .
The remaining genes in the 28 'cancer' genes identified as upregulated and hypomethylated, as with the acute RE analysis, this included genes implicated in TGF-beta signalling (TGFB3, TGFBR2, LEF1 and MECOM) after chronic RE in human skeletal muscle. These associated transcripts included: TGFB3
(Transforming growth factor beta-3) itself, TGF-beta receptor type-2 (TGFBR2) a receptor for the TGF-beta ligands TGFB1, TGFB2 & TGFB3 as well as; LEF1, that is associated with WNT-TCF/LEF and TGF-Beta-SMAD3 signalling in controlling muscle stem cell proliferation and self-renewal 64 . Finally, MECOM (alias EVI-1) has been demonstrated to play a role in growth regulation via TGF-beta/SMAD signalling 65 .
However, to the authors knowledge, MECOM has not been studied specifically in skeletal muscle anabolism or hypertrophy.
Collectively, we identify important epigenetically regulated 'cancer' genes that are associated with ECM/Actin structure and remodelling, mechano-transduction/focal adhesion (e.g. FAK and PLD) and TGF-Beta signalling after chronic RE in human skeletal muscle. While these were also the gene pathways associated with acute RE analysis above, it is worth noting that only two of the same genes, CTTN and FLNB were increased and hypomethylated after both acute and chronic resistance exercise analysis, and there were no other genes that were downregulated and hypermethylated that appeared in both acute and chronic transcriptome analysis. This suggested that while 'cancer' pathways, important in skeletal muscle matrix/ actin structure and remodelling, mechano-transduction and TGF-Beta signalling were important after both acute and chronic resistance exercise, the longer-term adaption to chronic exercise seems to be regulated by different genes within the same pathways versus a single bout of resistance exercise.
Newly Identified Epigenetic Memory Genes in Human Skeletal Muscle
51 genes were identified to be up/downregulated in both the acute and chronic RE transcriptomic analysis as well as significantly hypo/hypermethylated after acute RE, chronic RE, detraining and retraining. Five genes (MYH9, SRGAP1, SRGN, ZMIZ1, FLNB) demonstrated increased gene expression in the acute and chronic RE transcriptome while also demonstrating hypomethylation in these conditions. Importantly, these 5 genes also retained hypomethylation even during detraining (following training induced hypertrophy) when exercise completely cessed and lean mass returned to baseline (pre-training) levels. We therefore suggest,
given the retention of epigenetic information within CpG sites of these transcripts, that these may be newly identified memory genes that warrant further investigation. Interestingly MYH9, while it has been shown to be expressed at the gene level in skeletal muscle tissue, it is not thought to be translated into the protein and is therefore classed as a non-muscle myosin heavy chain. Therefore, it could be hypothesised that its hypomethylation and increased gene expression has other, yet undescribed, post-transcriptional functions in skeletal muscle anabolism and hypertrophy. SRGAP1 is a GTPase-activating protein for RhoA and Cdc42 small GTPases 66,67 and therefore, while potentially important in mechano-transduction, has not been studied in skeletal muscle. Serglycin (SRGN) is a proteoglycan that has been shown to increase its expression after acute and chronic aerobic exercise in humans, with cultured human muscle derived cells both expressing and secreting serglycin 68 . However, to the authors knowledge SRGN has not been studied after resistance exercise at either the gene expression of DNA methylation level, yet we identify it as a potential gene involved in epigenetic muscle memory. ZMIZ1 is a transcriptional co-activator that modules the transcription of androgen receptor (AR), SMAD3/4, and p53 in other cell types [69] [70] [71] . However, its role in skeletal muscle is yet undefined. Intriguingly, AR, SMAD and p53 are all important regulators of skeletal muscle mass and metabolism and therefore this gene requires further investigation as to its epigenetic role in skeletal muscle.
Finally, Filamin B (FLNB) was also identified in the gene expression and methylation analysis in both acute and chronic pooled transcriptome data and was significantly enriched in 'cancer pathways' in both the pooled transcriptome and methylome. At the protein level filamin B is involved in connecting the cell membrane constituents to the actin cytoskeleton, where mutations of the gene are inextricably linked to several myopathies 26 . From an exercise-induced response/adaptation perspective, there is limited information regarding the role of Filamin B in skeletal muscle following RE. Interestingly, Filamin A (protein family member) has been shown to be a substrate of Akt, and to be phosphorylated after endurance exercise, but not after resistance exercise 56 . More so, Filamin C has been shown to be altered following RE, and is closely associated with autophagy processes altered after resistance exercise 57 . Experimentally, we were able to confirm that Filamin B was increased at the gene expression level after acute and chronic RE and remained elevated (but non-significantly) after detraining and retraining where the gene remained as hypomethylated even during exercise cessation (detraining). However, increases in FLNB were only significant after acute RE. Despite this, and given the associated sustained hypomethylation, we suggest that this gene requires further mechanistic investigation as to its role in skeletal muscle anabolism, hypertrophy and memory.
Conclusion
Importantly, for the first time across both the transcriptome and methylome, this study identifies novel epigenetically regulated genes with predominant roles in human skeletal muscle ECM/ actin structure and remodelling, mechano-transduction as well as TGF-beta signalling associated with anabolism, hypertrophy and memory. Note: 5752 / 4604 total hypo/hypermethylated CpGs after acute RE is different than the original paper reporting 9,153 / 8,212 hypo/hypermethylated CpGs. This is due to the number of CpG's that resided on the shared list of 14,992 annotated genes by 'gene symbol' across the pooled transcriptomic studies for acute RE, depicted above in 1A, in order to provide a direct comparison of CpG sites on the same genes from the pooled transcriptomic data set. File 3E for the full KEGG 'Pathways in Cancer' gene list used to create the pathway diagram. File 3F for the full KEGG 'Proteoglycans in cancer' gene list used to create the pathway diagram. SRGAP1, C; SRGN, D; ZMIZ1 and E; FLNB demonstrated increased gene expression in both the transcriptome analysis after both acute and chronic RE and also demonstrated hypomethylation in these conditions in the methylome analysis. Importantly, these genes also demonstrated retained hypomethylation even during detraining (following training induced hypertrophy) when exercise was completely cessed and lean mass in the original study 12 returned to baseline (pre-training) levels. Figure 12 
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